Status:
UNKNOWN
Regulation of Vitamin D Receptor (VDR),Calcium Sensing Receptor (CaSR), Cyclin D1,Ki67 and Proliferating Cell Nuclear Antigen (PCNA) in Primary Hyperparathyroidism
Lead Sponsor:
Post Graduate Institute of Medical Education and Research, Chandigarh
Conditions:
Primary Hyperparathyroidism (PHPT)
Eligibility:
All Genders
Brief Summary
The present study is designed to examine the expression of VDR, CaSR, PTH, Cyclin D1, Ki67 and PCNA and to find out its relationship with clinical parameters in parathyroid adenomas. Examination of th...
Detailed Description
Introduction: Primary hyperparathyroidism (PHPT) is the third most frequent endocrine disorder, after diabetes mellitus and thyroid disorders, that predominantly affects postmenopausal women, with an...
Eligibility Criteria
Inclusion
- Patients with surgically verified sporadic PHPT
Exclusion
- Patients with hyperplasia, renal failure and multiple endocrine neoplasia
Key Trial Info
Start Date :
October 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2013
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01228786
Start Date
October 1 2007
End Date
June 1 2013
Last Update
July 20 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
PGIMER
Chandigarh, Uttarakhand, India, 1600012